Literature DB >> 12669036

Safety of retroviral gene marking with a truncated NGF receptor.

C Bonini, M Grez, C Traversari, F Ciceri, S Marktel, G Ferrari, M Dinauer, M Sadat, A Aiuti, S Deola, M Radrizzani, A Hagenbeek, J Apperley, S Ebeling, A Martens, H J Kolb, M Weber, F Lotti, A Grande, E Weissinger, J A Bueren, M Lamana, J H F Falkenburg, M H M Heemskerk, T Austin, S Kornblau, F Marini, C Benati, Z Magnani, S Cazzaniga, S Toma, C Gallo-Stampino, M Introna, S Slavin, P D Greenberg, M Bregni, F Mavilio, C Bordignon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12669036     DOI： 10.1038/nm0403-367

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  53 in total

1.  An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies.

Authors:  Carlos Almeida Ramos; Zahra Asgari; Enli Liu; Eric Yvon; Helen E Heslop; Clio M Rooney; Malcolm K Brenner; Gianpietro Dotti
Journal:  Stem Cells       Date:  2010-06       Impact factor: 6.277

2.  Simplified process for the production of anti-CD19-CAR-engineered T cells.

Authors:  Barbara Tumaini; Daniel W Lee; Tasha Lin; Luciano Castiello; David F Stroncek; Crystal Mackall; Alan Wayne; Marianna Sabatino
Journal:  Cytotherapy       Date:  2013-08-28       Impact factor: 5.414

Review 3.  Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies.

Authors:  X Wang; I Rivière
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

4.  Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.

Authors:  Zhongde Wang; Corinna La Rosa; Zhongqi Li; Heang Ly; Aparna Krishnan; Joy Martinez; William J Britt; Don J Diamond
Journal:  Vaccine       Date:  2006-10-06       Impact factor: 3.641

5.  Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells.

Authors:  Alessandra Recchia; Chiara Bonini; Zulma Magnani; Fabrizia Urbinati; Daniela Sartori; Sara Muraro; Enrico Tagliafico; Attilio Bondanza; Maria Teresa Lupo Stanghellini; Massimo Bernardi; Alessandra Pescarollo; Fabio Ciceri; Claudio Bordignon; Fulvio Mavilio
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

6.  Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design.

Authors:  Giulietta Maruggi; Simona Porcellini; Giulia Facchini; Serena K Perna; Claudia Cattoglio; Daniela Sartori; Alessandro Ambrosi; Axel Schambach; Christopher Baum; Chiara Bonini; Chiara Bovolenta; Fulvio Mavilio; Alessandra Recchia
Journal:  Mol Ther       Date:  2009-03-17       Impact factor: 11.454

7.  T-cell receptor gene transfer for the treatment of leukemia and other tumors.

Authors:  Mirjam H M Heemskerk
Journal:  Haematologica       Date:  2010-01       Impact factor: 9.941

Review 8.  Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy.

Authors:  Piyanuch Kongtim; Dean A Lee; Laurence J N Cooper; Partow Kebriaei; Richard E Champlin; Stefan O Ciurea
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-11       Impact factor: 5.742

9.  Haploidentical HSCT: a 15-year experience at San Raffaele.

Authors:  C Bonini; J Peccatori; M T L Stanghellini; L Vago; A Bondanza; N Cieri; R Greco; M Bernardi; C Corti; G Oliveira; E Zappone; C Traversari; C Bordignon; F Ciceri
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

Review 10.  CARs in chronic lymphocytic leukemia -- ready to drive.

Authors:  Chitra Hosing; Partow Kebriaei; William Wierda; Bipulendu Jena; Laurence J N Cooper; Elizabeth Shpall
Journal:  Curr Hematol Malig Rep       Date:  2013-03       Impact factor: 3.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.